[1] |
Wang Ying, Liu Nan, Guo Bing.
Advances of antibody-drug conjugate in the therapy of metastatic breast cancer
[J]. Journal of International Oncology, 2024, 51(6): 364-369.
|
[2] |
Wang Peixin, Zhao Jun, Xu Shihong, Jiang Zhaoyang, Wang Xiaoqiang, Yang Hongjuan.
Progress of ferroptosis-related mechanisms in osteosarcoma
[J]. Journal of International Oncology, 2024, 51(5): 308-311.
|
[3] |
Yang Zhi, Lu Yiqiao, Gu Huayan, Ding Jialing, Guo Guilong.
Research progress of tumor microenvironment mediated drug resistance in targeted therapy of breast cancer
[J]. Journal of International Oncology, 2024, 51(4): 235-238.
|
[4] |
Gong Yan, Chen Honglei.
Research progress on the mechanism of microRNA regulation of cisplatin resistance in ovarian cancer
[J]. Journal of International Oncology, 2024, 51(3): 186-190.
|
[5] |
Huang Hui, Ding Jianghua.
Advances in targeting FGFR2 for treatment of advanced cholangiocarcinoma
[J]. Journal of International Oncology, 2023, 50(9): 569-573.
|
[6] |
An Rong, Liu Meihua, Wang Peichen, Wang Xiaohui.
Research progress of Nrf2 in ovarian cancer
[J]. Journal of International Oncology, 2023, 50(8): 493-497.
|
[7] |
Li Chenxi, Zhao Hongwei.
Prognosis and influencing factors of platinum sensitive recurrent ovarian cancer treated by secondary cytoreduction surgery in patients with unsatisfactory primary cytoreduction surgery
[J]. Journal of International Oncology, 2023, 50(6): 342-347.
|
[8] |
Li Qingshan, Xie Xin, Zhang Nan, Liu Shuai.
Research progress on the application of combining radiotherapy and systemic therapy in breast cancer
[J]. Journal of International Oncology, 2023, 50(6): 362-367.
|
[9] |
Liu Li, Zhu Siqi, Sun Mengying, He Jingdong.
Progress of PARP inhibitors in targeted therapy of small cell lung cancer
[J]. Journal of International Oncology, 2023, 50(6): 368-372.
|
[10] |
Liu Bohan, Huang Junxing.
Research progress of solute carriers related genes in malignant tumors
[J]. Journal of International Oncology, 2023, 50(5): 280-284.
|
[11] |
Yang Lirong, Wang Yufeng.
Construction of machine learning models for predicting the risk of postoperative distant metastasis recurrence in serous ovarian cancer
[J]. Journal of International Oncology, 2023, 50(4): 220-226.
|
[12] |
Zhu Jun, Huang Meijin, Li Yuan, Liu Zegang, Xun Xin, Chen Hong.
Research progress on targeted therapy of breast cancer with low expression of HER2
[J]. Journal of International Oncology, 2023, 50(4): 236-240.
|
[13] |
Deng Lili, Duan Xingyu, Li Baozhong.
Advances of anti-HER2 targeted drugs and combined therapeutic regimens for gastric and esophagogastic adenocarcinoma
[J]. Journal of International Oncology, 2023, 50(12): 751-757.
|
[14] |
Liu Shaoping, Luo Hanchuan, Lin Shuhan, Luo Jiahui.
Current status and research progress of interventional and systemic therapy for advanced hepatocellular carcinoma
[J]. Journal of International Oncology, 2023, 50(12): 758-762.
|
[15] |
Jiang Shan, Xu Ximing.
Recent progresses of targeted therapy and immunotherapy of hepatocellular carcinoma
[J]. Journal of International Oncology, 2023, 50(11): 688-695.
|